SCHEMBL2006064

SCHEMBL2006064

COc1ncccc1N(C(=O)O)C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC13A5 Q86YT5 1/20 0.41
TDP1 Q9NUW8 1/20 0.38
FFAR4 Q5NUL3 1/20 0.36
GPBAR1 Q8TDU6 1/20 0.36
MAPT P10636 2/20 0.36
GAA P10253 1/20 0.36
APLNR P35414 1/20 0.36
BTK Q06187 1/20 0.35
SLC22A12 Q96S37 1/20 0.35
DHODH Q02127 1/20 0.35
NFE2L2 Q16236 3/20 0.35
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
CYP3A4 P08684 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
BLM P54132 1/20 0.34
AGER Q15109 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL238763 0.78 SMN1; SMN2 (0.46) TDP1MAPTDHODHKDM4EALDH1A1
SCHEMBL5582871 0.78 KDM4E (0.36) TDP1MAPTKDM4EALDH1A1CYP3A4
SCHEMBL118711 0.78 MEN1 (0.46) MAPTSLC22A12KDM4EALDH1A1L3MBTL1
SCHEMBL8699109 0.76 TDP1 (0.41) SLC13A5TDP1MAPTGAADHODH
SCHEMBL17467141 0.76 POLB (0.37) TDP1KDM4EALDH1A1L3MBTL1POLB
SCHEMBL21598413 0.75 TDP1 (0.40) SLC13A5TDP1FFAR4MAPTGAA
SCHEMBL5655590 0.74 CA12 (0.43) MAPTALDH1A1L3MBTL1POLB
SCHEMBL6615497 0.74 CHRM2 (0.36) MAPTKDM4EALDH1A1CYP3A4ALOX15
SCHEMBL22589893 0.74 ALDH1A1 (0.38) MAPTKDM4EALDH1A1L3MBTL1POLB
SCHEMBL16812908 0.73 APLNR (0.43) SLC13A5TDP1APLNRBTKNFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960394-B2 3,8-dimethyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]-4(3H)-quinazolinone; 6-chloro-3-methyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]pyrido[3,4-d]-pyrimidin-4(3H)-one; 2-[4-(1-cyclopentyl-4-piperidinyloxy)phenyl]-3-methylpyrido[2,3-d]-pyrimidin-4(3H)-one; treats metabolic, nervous system, vascular disorders BANYU PHARMACEUTICAL CO., LTD. (JP) 2011-06-14 US disclosed